Global Information
회사소개 | 문의 | 비교리스트

겨드랑이 다한증 : 역학 인사이트(-2030년)

Axillary Hyperhidrosis - Epidemiology Insight - 2030

리서치사 DelveInsight Business Research LLP
발행일 2020년 11월 상품 코드 966755
페이지 정보 영문 50 Pages
가격
US $ 3,750 ₩ 4,191,000 PDF (Single User License)
US $ 7,500 ₩ 8,382,000 PDF (Site License)
US $ 11,250 ₩ 12,574,000 PDF (Global License)


겨드랑이 다한증 : 역학 인사이트(-2030년) Axillary Hyperhidrosis - Epidemiology Insight - 2030
발행일 : 2020년 11월 페이지 정보 : 영문 50 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

주요 7개국(미국, 독일, 프랑스, 이탈리아, 스페인, 영국, 일본)의 겨드랑이 다한증(Axillary Hyperhidrosis) 역학과 관련 시장에 대해 조사한 것으로, 질환의 배경과 개요, 역학과 환자수, 현재의 치료법, KOL(Key Opinion Leadaer)의 견해, 충족되지 않은 욕구 등의 정보를 제공합니다.

목차

제1장 주요 조사 결과

제2장 개요

제3장 질환의 배경과 개요

  • 서론
  • 징후와 증상
  • 병태생리학
  • 위험인자
  • 진단

제4장 환자 치료 과정

제5장 역학과 환자수

  • 주요 조사 결과
  • 전제조건과 근거 : 주요 7개국
  • 역학 시나리오 : 주요 7개국
    • 주요 7개국의 역학 시나리오
  • 미국
  • 유럽 5개국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
  • 일본

제6장 치료 알고리즘, 현재의 치료와 의료

  • 치료와 관리
  • 치료 알고리즘

제7장 KOL(Key Opinion Leadaer)의 견해

제8장 충족되지 않은 욕구

제9장 부록

  • 참고 문헌
  • 보고서의 조사 방법

제10장 DelveInsight의 서비스 내용

제11장 면책사항

제12장 DelveInsight에 대해

LSH 20.11.04

List of Tables

  • Table 1 Summary of Axillary Hyperhidrosis Epidemiology and Key Events (2017-2030)
  • Table 2 Sweating rates by gravimetric measurement
  • Table 3 Hyperhidrosis Disease Severity Scale (HDSS)
  • Table 4 Total Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 5 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 6 Age-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 7 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 8 Severity-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)

List of Figures

  • Figure 1 Summary of Axillary Hyperhidrosis Epidemiology and Key Events (2017-2030)
  • Figure 2 Sweating rates by gravimetric measurement
  • Figure 3 Hyperhidrosis Disease Severity Scale (HDSS)
  • Figure 4 Total Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 5 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 6 Age-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 7 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 8 Severity-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)

DelveInsight's 'Axillary Hyperhidrosis (AH)-Epidemiology Forecast-2030' report delivers an in-depth understanding of the Axillary Hyperhidrosis (AH), historical and forecasted epidemiology as well as the Axillary Hyperhidrosis (AH) trends in the United States.

Axillary Hyperhidrosis (AH) Disease Understanding

Axillary hyperhidrosis, a form of excessive sweating from armpits, is a disease that affects the social and occupational lives of many people on all continents. Axillary hyperhidrosis begins during the teenage years and equally affects men and women. Hyperhidrosis initially begins from the hands and feet during early childhood, whereas axillary hyperhidrosis often starts in adolescence. When associated with axillary malodor, it is known as bromhidrosis. The sweat glands-small tubular structures in the skin-secrete sweat onto the skin via a duct. Eccrine sweat glands are distributed throughout the body, and they secrete sweat directly onto the surface of the skin. Apocrine sweat glands are 10 times larger than eccrine sweat glands. They are localized in the axilla (underarms) and perianal areas.

The various causes of hyperhidrosis can be compounded by anxiety and stress. They can range from moderate moisture to severe dripping, which can, in turn, exacerbate the associated anxiety and stress. Excessive armpit sweating may be caused by genetic predisposition, medications, neurologic/metabolic, or other systemic diseases, hormonal changes such as menopause, social anxiety, stress, nervousness, or unknown factors.

Axillary Hyperhidrosis (AH) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of Axillary Hyperhidrosis, Diagnosed Prevalence of Axillary Hyperhidrosis, Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States from 2017 to 2030.

Axillary Hyperhidrosis (AH) Detailed Epidemiology Segmentation

  • As per DelveInsight's analysis, there was a total of 10,162,438 Axillary Hyperhidrosis prevalent cases in 2017.
  • As per DelveInsight's analysis, a total of 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017.
  • In 2017, 327,129 cases accounted for <18 years, 1,635,035 cases for 18-39 years, 872,852 cases for 40-64 years and (213,716) remaining cases for 65+ years.
  • As per DelveInsight's analysis, a total of 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017, Out of which 93% accounted for Primary hyperhidrosis and 7% accounted for secondary hyperhidrosis.
  • As per DelveInsight's analysis, 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017, out of which 52% accounted for severe HDSS scale 3 or 4 and 48% accounted for Non-severe HDSS scale 1 or 2.

Scope of the Report:

  • The report covers the descriptive overview of Axillary Hyperhidrosis (AH), explaining its signs and symptoms, and pathophysiology.
  • The report provides insight into the United States historical and forecasted patient pool.
  • The report assesses the disease risk and burden and highlights the unmet needs of Axillary Hyperhidrosis (AH).
  • The report helps to recognize the growth opportunities in the United States with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for United States by Total Pravelent Cases of Axillary Hyperhidrosis (AH), Gender-specific Incident Cases of Axillary Hyperhidrosis (AH), Diagnosed Prevalence of Axillary Hyperhidrosis, Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis.

Report Highlights:

  • 11-Year Forecast of Axillary Hyperhidrosis (AH)
  • United States Coverage
  • Total Pravelent Cases of Axillary Hyperhidrosis (AH)
  • Diagnosed Prevalence of Axillary Hyperhidrosis
  • Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis
  • Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis
  • Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis

Key Questions Answered

  • What are the disease risk, burdens, and unmet needs of Axillary Hyperhidrosis (AH)?
  • What is the historical Axillary Hyperhidrosis (AH) patient pool in the United States?
  • What would be the forecasted patient pool of Axillary Hyperhidrosis (AH) at the United States level?
  • What will be the growth opportunities across the United States with respect to the patient population pertaining to Axillary Hyperhidrosis (AH)?
  • At what CAGR the population is expected to grow across the United States during the forecast period (2020-2030)?

Reasons to buy:

The Axillary Hyperhidrosis (AH) report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the United States Axillary Hyperhidrosis (AH) epidemiology forecast.
  • The Axillary Hyperhidrosis (AH) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Axillary Hyperhidrosis (AH) epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States

Study Period: 2017-2030

Table of Contents

1 Key Insights

2 Executive Summary of Axillary Hyperhidrosis (AH)

3 Disease Background and Overview: Axillary Hyperhidrosis

  • 3.1. Introduction
  • 3.2. Types and Underlying Causes of Hyperhidrosis
  • 3.3. Symptoms of Axillary hyperhidrosis
  • 3.4. Pathophysiology of Axillary hyperhidrosis
  • 3.5. Diagnosis
    • 3.5.1. Diagnostic Algorithm

4 Patient Journey

5 Epidemiology and Patient Population

  • 5.1 Key Findings
  • 5.2 KOL Views
  • 5.3 Epidemiology Methodology
  • 5.4 Assumptions and Rationale
  • 5.5 Total Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.6 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.7 Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.8 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.9 Severity Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States

6 Appendix

  • 6.1 Bibliography
  • 6.2 Report Methodology

7 DelveInsight Capabilities

8 Disclaimer

9 About DelveInsight

Back to Top
전화 문의
F A Q